Skip to main content
. 2018 May 31;2018(5):CD003220. doi: 10.1002/14651858.CD003220.pub3

36. Pulpectomy (Vitapex) versus pulpectomy (CH).

Outcome Time point (months) No. of studies Risk ratio (95% CI)
Clinical failure 6 1 0.33 (0.01 to 7.72)
12 1 0.11 (0.01 to 1.94)
Radiological failure 6 and 12 1 0.11 (0.01 to 1.94)
Pain 6 and 12 1 0.33 (0.01 to 7.72)
Pathological mobility 6 and 12 1 0.33 (0.01 to 7.72)
Pathological radiolucency 6 and 12 1 0.20 (0.01 to 3.92)
Pathological root resorption 6 and 12 1 Not estimable*
Filling material anomaly 6 and 12 1 3.00 (0.13 to 69.52)

*due to lack of events

Abbreviations ‐ CI: confidence interval; Vitapex: CH/iodoform; CH: calcium hydroxide.